| Year |
Citation |
Score |
| 2020 |
Durante MA, Rodriguez DA, Kurtenbach S, Kuznetsov JN, Sanchez MI, Decatur CL, Snyder H, Feun LG, Livingstone AS, Harbour JW. Single-cell analysis reveals new evolutionary complexity in uveal melanoma. Nature Communications. 11: 496. PMID 31980621 DOI: 10.1038/S41467-019-14256-1 |
0.392 |
|
| 2020 |
Owens DA, Kuznetsov JN, Lopez A, Kurtenbach S, Bilbao D, Roberts ER, Volmar C, Wahlestedt CR, Harbour JW. Abstract 4025: New candidate therapy for BAP1-mutant cancer identified using novel screen Cancer Research. 80: 4025-4025. DOI: 10.1158/1538-7445.Am2020-4025 |
0.365 |
|
| 2019 |
Kuznetsov JN, Aguero TH, Owens DA, Kurtenbach S, Field MG, Durante MA, Rodriguez DA, King ML, Harbour JW. BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers. Science Advances. 5: eaax1738. PMID 31555735 DOI: 10.1126/Sciadv.Aax1738 |
0.4 |
|
| 2019 |
Recker KL, Norton S, Sobh A, Riva A, Chang K, Kuznetsov J, Durante M, Flores F, Bennett RL, Vakoc C, Smalley K, Harbour W, Licht JD. Synthetic Lethal Screen to Identify Molecular Mechanisms that Drive Uveal Melanoma Uf Journal of Undergraduate Research. 21. DOI: 10.32473/ufjur.v21i1.108370 |
0.383 |
|
| 2019 |
Owens DA, Kuznetsov JN, Kurtenbach S, Agüero T, King ML, Harbour JW. Abstract 5199: A novel role for BAP1 in development and tumor suppression Cancer Research. 79: 5199-5199. DOI: 10.1158/1538-7445.Am2019-5199 |
0.337 |
|
| 2013 |
Leclerc GM, Leclerc GJ, Kuznetsov JN, DeSalvo J, Barredo JC. Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts. Plos One. 8: e74420. PMID 24009772 DOI: 10.1371/Journal.Pone.0074420 |
0.766 |
|
| 2012 |
DeSalvo J, Kuznetsov JN, Du J, Leclerc GM, Leclerc GJ, Lampidis TJ, Barredo JC. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia. Molecular Cancer Research : McR. 10: 969-78. PMID 22692960 DOI: 10.1158/1541-7786.Mcr-12-0125 |
0.767 |
|
| 2012 |
Kuznetsov JN, DeSalvo J, Du J, Leclerc GM, Leclerc GJ, Lampidis TJ, Barredo JC. Abstract 4991: Akt and AMPK modulate UPR activity and determine ER stress-induced cell death in response to 2-DG in ALL Cancer Research. 72: 4991-4991. DOI: 10.1158/1538-7445.Am2012-4991 |
0.764 |
|
| 2012 |
Leclerc GM, Leclerc GJ, Kuznetsov JN, Barredo JC. Abstract 2736: PIM2 is up-regulated in response to metformin-induced cell death triggered by ER stress/UPR in ALL lymphoblasts Cancer Research. 72: 2736-2736. DOI: 10.1158/1538-7445.Am2012-2736 |
0.772 |
|
| 2011 |
Kuznetsov JN, Leclerc GJ, Leclerc GM, Barredo JC. AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia. Molecular Cancer Therapeutics. 10: 437-47. PMID 21262957 DOI: 10.1158/1535-7163.Mct-10-0777 |
0.752 |
|
| 2011 |
Leclerc GM, Leclerc GJ, Kuznetsov JN, Barredo JC. PIM2 Upregulation Leads to Physiological Buffering of Metformin-Induced Cell Death Mediated by ER Stress/UPR in Acute Lymphoblastic Leukemia, Blood. 118: 3496-3496. DOI: 10.1182/Blood.V118.21.3496.3496 |
0.77 |
|
| 2011 |
Leclerc GM, Leclerc GJ, Kuznetsov J, Barredo JC. Abstract 605: A novel role for AMPK as a molecular switch regulating the activation of Akt and RAS signaling in acute lymphoblastic leukemia Cancer Research. 71: 605-605. DOI: 10.1158/1538-7445.Am2011-605 |
0.735 |
|
| 2010 |
Leclerc GM, Kuznetsov JN, Barredo JC. Abstract 5089: AMPK activationvs.inhibition induces apoptosis in acute lymphoblastic leukemia cells by differentially altering PI3K/Akt/mTOR or RAS/cRAF/MEK/Erk signaling Cancer Research. 70: 5089-5089. DOI: 10.1158/1538-7445.Am10-5089 |
0.744 |
|
| Show low-probability matches. |